ICOS sustains T FH and allergic airway disease

INTRODUCTION 51
Allergic asthma is a disease of chronic airway inflammation and remodeling, associated with 52 a dysregulated type 2 immune response. The disorder is driven by chronic exposure to 53 aeroallergens, including house dust mite (HDM) and fungal spores, leading to production of 54 type 2 cytokines, IL-4, IL-5 and IL-13, and the hallmark symptoms of allergen specific 55 immunoglobulin E (IgE), eosinophilia and airway hyper-responsiveness (AHR)
56
Traditionally, the disorder has been described as a T helper 2 (Th2) cell disease, as they 57 produce type 2 cytokines which drive the pathophysiology. However, it is now clear that 58 multiple other cells of the immune system can produce these cytokines and thus could play 
65
T FH differentiation is a multi-step process. Firstly, within the T cell zone, naive CD4 + T cells 
74
A handful of studies have now attempted to dissect the role of T FH during AAD pathogenesis.
75
T FH have been identified in the lymph nodes and spleens of HDM sensitised and challenged 76 animals [13] [14] [15] and have been shown to be critical to the production of allergen specific IgE 16, 17 .
77
T FH generated in lung draining lymph nodes have been shown to become 
84
Taken together, these studies imply T FH are important to allergic disease but their precise 85 role remains unclear, and the therapeutic potential of targeting them is untested.
87
In this study using two chronic allergen exposure models mimicking the repeated 
RESULTS 104
Chronic allergen exposure generates local and systemic T FH responses
105
Allergic asthma is a disease of chronic pulmonary inflammation driven by repeated low dose 106 exposure to aeroallergens. To mimic the pathogenesis in vivo and determine if responses 107 were antigen dependent, mice were exposed to two common aeroallergens; either house 108 dust mite (HDM) or Alternaria alternata (ALT) 3 times a week for up to 5 weeks ( Figure 1A ). 
113
Continued allergen exposure further increased T FH proportions in the mLN after 3 and 5
114
weeks. ( Figure 1B , C and Supplementary figure S1A). Elevated T FH frequencies were also 115 found in the spleen, but only after 3 weeks of allergen exposure ( Figure 1D , E and
116
Supplementary figure S1B). Moreover, T FH were observed at the site of inflammation, with
117
HDM inhalation causing consistently elevated lung T FH frequencies between weeks 3 and 5
118
( Figure 1F , Supplementary figure S1C). ALT lung T FH were significantly increased at 3 119 weeks compared to PBS controls but only reached a frequency comparable to HDM after 5 120 weeks of exposure ( Figure 1G , Supplementary figure S1C 
134
Lung GC B cells were also observed in HDM exposed animals at 3 weeks ( Figure 2B and
135
Supplementary figure S3B), while only after 5 weeks of ALT exposure were lung GC B cell 136 frequencies significantly increased compared to PBS controls ( Figure 2D and
137
Supplementary figure S3B) . Similarly, GC B cells were identified in the spleen of allergen 138 exposed animals after 3 weeks (Supplementary figure S3C) .
140
Allergen specific antibody, in particular IgE, is a hallmark feature of AAD. Total and allergen
141
specific IgE and IgG1 were only detectable in allergen exposed mice after 3 weeks ( Figure   142 2E-L). Sustained exposure to HDM did not further alter the concentration of total or specific
143
IgE ( Figure 2E, I ), but did increase IgG1 production ( Figure 2F , J). Total and ALT specific
144
IgE and IgG1 were substantially increased at 5 weeks compared to 3 weeks ( Figure 2G , H,
145
K, L). Allergen specific antibodies were undetectable in the serum of PBS exposed animals
146
( Figure 2I-L 
155
or an isotype control (2A3) in the last two weeks of allergen exposure (weeks 4 and 5). Mice
156
were culled at the end of week 5 (Supplementary figure S4) . 3 weeks of allergen exposure inflammation, eosinophilia and AHR [23] [24] [25] . -ICOS-L treatment substantially reduced mLN and 159 lung T FH populations after HDM exposure compared to 2A3 treated animals ( Figure 3A -C).
160
Similar results were observed with ALT ( Figure 
180
Total lung eosinophils were reduced with allergen and -ICOS-L co-administration ( Figure   181 4C, D), however, the proportions of lungs eosinophils were unchanged (Supplementary 182 figure S6 ). 
226
Supplementary figure S9A, 
254
In this study, we showed that T FH populations were generated in the peripheral lymph nodes 255 and with prolonged allergen challenge could be detected locally within the lungs. 
675
Adult female BALB/c mice were exposed to either 25 µg house dust mite (HDM), 10 µg 
680
Lungs. Antibody within the serum was assessed by ELISA. E) HDM total IgE, F) HDM total
681
IgG1, G) ALT total IgE, H) ALT total IgG1. Serum was titrated and allergen specific IgE and 
696
ALT Lung. K-N) Serum was titrated and allergen specific antibody measured by ELISA.
697
Endpoint titres are displayed. K) HDM specific IgE, L) ALT specific IgE, M) HDM specific
698
IgG1, N) ALT specific IgE. Statistical significance was determined using a Mann Whitney U 699 test. * P<0.05, **p<0.01, ***p<0.001. HDM data shown is pooled from two independent 700 experiments, n=8-12. ALT data is based on one study, n=4-6. 
703
Adult female BALB/c mice were exposed (i.n) to 25 µg house dust mite (HDM), 10 µg 
F) G )
Figure 2: Allergen driven T FH generation precedes germinal centre formation and antibody production. Adult female BALB/c mice were exposed to either 25 µg house dust mite (HDM), 10 µg alternaria alternata (ALT) or 25 µl phosphate buffered saline (PBS), 3 times a week for up to 5 weeks. Flow cytometry was used to determine the frequency of germinal centre (GC) B cells in the mLN and lungs. GC B cell were defined as CD38 -GL7 + FAS + CD19 + B220 + lymphocytes and quantified. HDM study, A) mLN, B) Lungs, and ALT study, C) mLN, D) Lungs. Antibody within the serum was assessed by ELISA. E) HDM total IgE, F) HDM total IgG1, G) ALT total IgE, H) ALT total IgG1. Serum was titrated and allergen specific IgE and IgG1 was measured by ELISA. Endpoint titres are displayed. I) HDM-specific IgE, J) HDM-specific IgG1, K) ALT-specific IgE, L) ALT-specific IgG1. Statistical significance was determined using a Mann Whitney U test. * P<0.05, **p<0.01, ***p<0.001. n=4-5 mice per time-point. Representative data from 2 independent experiments. HDM specific IgE, L) ALT specific IgE, M) HDM specific IgG1, N) ALT specific IgE. Statistical significance was determined using a Mann Whitney U test. * P<0.05, **p<0.01, ***p<0.001. HDM data shown is pooled from two independent experiments, n=8-12. ALT data is based on one study, n=4-6. Adult female BALB/c mice were exposed (i.n) to 25 µg house dust mite (HDM), 10 µg alternaria alternata (ALT) or 25 µl phosphate buffered saline (PBS), 3 times a week for 5 weeks. From the start of week 4 mice were also administered 150 µg anti-ICOS-L (α-ICOS-L) or isotype control (2A3) antibody (i.p) 3 times a week. Mice were culled at the end of week 5. Total number of cells in the lung, A) HDM study, B) ALT study. Total number of lung eosinophils, C) HDM study, D) ALT study. E-H) Airway hyperresponsiveness was measured by exposing mice to 0-100mg/ml methacholine (MCh) using the flexiVent system during HDM induced allergic airway disease. E) airway resistance, F) airway compliance and G) airway elastance, H) Quantification of airway elastance at 30mg/ml MCh. I-L) Airway hyperresponsiveness was measured during ALT induced allergic airway disease. I) airway resistance, J) airway compliance and K) airway elastance, L) Quantification of airway elastance at 30mg/ml MCh. Curves display mean±SEM. * = statistical difference between allergen+2A3 and allergen+-ICOS-L. Statistical significance was determined using a Mann Whitney U test. * P<0.05, **p<0.01, ***p<0.001. HDM data shown is pooled from two independent experiments, n=8-12. ALT data is based on one study, n=4-6. HDM study, D) ALT study. IL-5, E) HDM Study, F) ALT study. Eotaxin-2, G) HDM study, H) ALT study. Statistical significance was determined using a Mann Whitney U test. * P<0.05, **p<0.01, ***p<0.001. HDM data shown is pooled from two independent experiments, n=8-12. ALT data is based on one study, n=4-6. Frequency of IL-13 + CD4 + T cells -ALT study, E) Total IL-13 + CD4 + T cells -ALT study, F) Total IL-13 + ILCs -HDM study, G) Total IL-13 + ILCs -ALT study. HDM data shown is pooled from two independent experiments, n=8-12. ALT data is based on one study, n=4-6. H-J) Adult female IL-13 GFP reporter mice were exposed (i.n) to 25 µg HDM or 25 µl PBS, 3 times a week for 3 weeks. Flow cytometry was used to determine the frequency of IL-13 GFP cells. 
